| Authors: |
Rugo HS; City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: hrugo@coh.org., Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; University of Milano, Milano, Italy., Cescon DW; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, France., Harbeck N; Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, Ludwig Maximilians University Munich University Hospital, Munich, Germany., Im SA; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Barrios C; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Modi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Tolaney SM; Brigham and Women's Hospital Dana-Farber Cancer Institute, Boston, MA, USA., Oliveira M; Vall d'Hebron Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. |
